![](/img/cover-not-exists.png)
Rapid clearance of rituximab may contribute to the continued high incidence of autoimmune hematologic complications of chemoimmunotherapy for chronic lymphocytic leukemia
Mo, C. C., Njuguna, N., Beum, P. V., Lindorfer, M. A., Vire, B., Lee, E., Marti, G., Wilson, W. H., Taylor, R. P., Wiestner, A.Volume:
98
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2012.080929
Date:
August, 2013
File:
PDF, 1000 KB
english, 2013